Spruce Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Spruce Biosciences Inc
TickerSPRB
CIK #0001683553
CUSIP85209E109
SectorLife Sciences - Pharmaceutical Preparations
Address2001 Junipero Serra Blvd, Suite 640, Daly City, CA 94104
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Spruce Biosciences Inc 2025-10-17 50.0 M Exemption: 506(b) · Duration: One year or less · Commission: $3,000,000 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001683553] 10-K
[0001683553] 10-Q
[0001683553] 3
[0001683553] 4
[0001683553] 8-K
[0001683553] D
[0001683553] SC 13D
[0001683553] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ExodusPoint Capital Management LP Spruce Biosciences Inc [2026-04-28] 0.0
Integrated Core Strategies US LLC Spruce Biosciences Inc [2026-02-24] 0.0
ADAR1 Capital Management LLC Spruce Biosciences Inc [2026-02-17] 0.0
Alyeska Investment Group LP Spruce Biosciences Inc [2026-02-17] 0.0
Wellington Management Group LLP Spruce Biosciences Inc [2026-02-10] 0.0
Boone Peter David Mr Spruce Biosciences Inc [2025-11-24] 0.0
Citadel Advisors LLC Spruce Biosciences Inc [2025-10-16] 0.0
Squadron Capital Management LLC Spruce Biosciences Inc [2025-10-15] 0.0
Ikarian Capital LLC Spruce Biosciences Inc [2025-10-08] 0.0
Radoff Bradley Louis Spruce Biosciences Inc [2024-03-28] 6.9
Armistice Capital LLC Spruce Biosciences Inc [2024-02-14] 5.48
Rosalind Advisors Inc Spruce Biosciences Inc [2024-01-30] 5.67
5AM Opportunities II LP Spruce Biosciences Inc [2023-02-27] 0.97
Flynn James E Spruce Biosciences Inc [2021-05-17] 6.09
Omega Fund VI LP Spruce Biosciences Inc [2021-02-12] 9.3
Elms Steve Spruce Biosciences Inc [2021-02-12] 5.18
FMR LLC Spruce Biosciences Inc [2021-02-08] 0.0
HealthCap VIII LP Spruce Biosciences Inc [2020-12-18] 8.8
Citadel Advisors LLC Spruce Biosciences Inc [2020-10-26] 7.3
Rivervest Venture Fund III LP Spruce Biosciences Inc [2020-10-23] 6.0
Rock Springs Capital Management LP Spruce Biosciences Inc [2020-10-19] 7.38
Abingworth LLP Spruce Biosciences Inc [2020-10-16] 7.7
Novo Holdings A/S Spruce Biosciences Inc [2020-10-16] 21.5
Form 3/4/5 Filer 2011 - 2026
Barretto-Ko Percival
Spruce Biosciences Inc
Spiegelman Daniel K
Simpson Camilla V
Grey Michael G
Walbert Keli
Hooks Corwin Dale
Ways Douglas Kirk
Szwarcberg Javier B
Gharib Samir M
Martinez Gregory
Parkman Healthcare Partners LLC
Aynechi Tiba
Muralidhar Bali
Charlton Ralph William III
Novo Holdings A/S
O'Donnell Niall
Chaya Moghrabi Dina
Dias Subaweerage
King Richard
Omega Fund VI LP
Omega Fund VI GP LP
Omega Fund VI GP Manager Ltd
HealthCap VIII LP
Hansson Jonas
RiverVest Venture Fund III LP
RiverVest Venture Fund IV LP
RiverVest Venture Fund III Ohio LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hooks Corwin Dale
Restricted Stock Units · derivative
2026-03-09 Grant 11,000 $0.00
Szwarcberg Javier B
Common Stock
2025-12-31 Grant 4,690 $4.53 21,246
Szwarcberg Javier B
Common Stock
2025-12-15 Option exercise 1,196 $0.00
Szwarcberg Javier B
Restricted Stock Units · derivative
2025-12-15 Option exercise 1,196 $0.00
Szwarcberg Javier B
Restricted Stock Units · derivative
2025-12-15 Option exercise 1,480 $0.00
Gharib Samir M
Common Stock
2025-12-15 Option exercise 496 $0.00
Gharib Samir M
Restricted Stock Units · derivative
2025-12-15 Option exercise 496 $0.00
Gharib Samir M
Restricted Stock Units · derivative
2025-12-15 Option exercise 513 $0.00
Gharib Samir M
Common Stock
2025-12-15 Tax withheld 178 $80.67 14,359
Gharib Samir M
Common Stock
2025-12-15 Option exercise 513 $0.00
Gharib Samir M
Common Stock
2025-12-15 Tax withheld 184 $80.67 14,843
Szwarcberg Javier B
Common Stock
2025-12-15 Tax withheld 608 $80.67 49,047
Szwarcberg Javier B
Common Stock
2025-12-15 Tax withheld 752 $80.67 60,664
Szwarcberg Javier B
Common Stock
2025-12-15 Option exercise 1,480 $0.00
Ways Douglas Kirk
Common Stock
2025-12-11 Option exercise 1,250 $0.00
Ways Douglas Kirk
Restricted Stock Units · derivative
2025-12-11 Option exercise 1,250 $0.00
Ways Douglas Kirk
Restricted Stock Units · derivative
2025-12-11 Grant 5,000 $0.00
Ways Douglas Kirk
Stock Option (Right to Buy) · derivative
2025-12-11 Grant 266
Ways Douglas Kirk
Stock Option (Right to Buy) · derivative
2025-12-11 Disposed to issuer 266
Ways Douglas Kirk
Stock Option (Right to Buy) · derivative
2025-12-11 Grant 400
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 32 746,125
2025-12-31 32 750,857
2025-09-30 9 2,937,895
2025-06-30 3 2,046,828
2025-03-31 32 10,451,600
2024-12-31 32 11,179,718
2024-09-30 32 13,631,622
2024-06-30 40 16,674,943
2024-03-31 52 18,109,049
2023-12-31 41 32,258,550
2023-09-30 42 31,887,003
2023-06-30 40 31,965,361
Form 13F Holdings
Firm Period DFND Voting Shares
Friedenthal Financial [2026-06-30] SOLE 0 7
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com